Mounting evidence indicates that escalating doses of allopurinol are unnecessary for cardiovascular protection: comment on the article by Coburn et al
Journal article published in 2018 by
Markus Bredemeier 
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 